Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 60 items for :

Clear All
Xu Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Xu Chen in
Google Scholar
PubMed Close
,
Yi Tang Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China

Search for other papers by Yi Tang in
Google Scholar
PubMed Close
,
Shen Chen Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China

Search for other papers by Shen Chen in
Google Scholar
PubMed Close
,
Wenhua Ling Department of Nutrition, School of Public Health, Sun Yat-Sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Wenhua Ling in
Google Scholar
PubMed Close
, and
Qing Wang Department of Toxicology, School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China
Guangdong Provincial Key Laboratory of Food, Nutrition and Health, Guangzhou, People’s Republic of China

Search for other papers by Qing Wang in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD), which is considered to be the hepatic manifestation of the metabolic syndrome is defined as the abnormal hepatic triglyceride (TG) accumulation without excessive alcohol use. NAFLD

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0353
Volume/Issue:
Volume 10: Issue 10
Open access
Zhiyan Yu Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Zhiyan Yu in
Google Scholar
PubMed Close
,
Yueyue Wu Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Yueyue Wu in
Google Scholar
PubMed Close
,
Rui Zhang Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Rui Zhang in
Google Scholar
PubMed Close
,
Yue Li Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Yue Li in
Google Scholar
PubMed Close
,
Shufei Zang Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Shufei Zang in
Google Scholar
PubMed Close
, and
Jun Liu Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China

Search for other papers by Jun Liu in
Google Scholar
PubMed Close

factor-1 and hypoalbuminemia. Non-alcoholic fatty liver disease (NAFLD) affecting multiple extrahepatic organs is considered a multi-system disease ( 2 ). Recent studies have shown that NAFLD is a high risk factor for osteoporosis ( 3 ). Several studies

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0174
Volume/Issue:
Volume 11: Issue 11
Open access
Rachel D C A Diniz
Search for other papers by Rachel D C A Diniz in
Google Scholar
PubMed Close
,
Renata M Souza
Search for other papers by Renata M Souza in
Google Scholar
PubMed Close
,
Roberto Salvatori Division of Endocrinology, Division of Endocrinology, Division of Hepatology, Division of Radiology, Diabetes and Metabolism, Federal University of Sergipe, Aracaju, Brazil

Search for other papers by Roberto Salvatori in
Google Scholar
PubMed Close
,
Alex Franca Division of Endocrinology, Division of Endocrinology, Division of Hepatology, Division of Radiology, Diabetes and Metabolism, Federal University of Sergipe, Aracaju, Brazil

Search for other papers by Alex Franca in
Google Scholar
PubMed Close
,
Elenilde Gomes-Santos
Search for other papers by Elenilde Gomes-Santos in
Google Scholar
PubMed Close
,
Thiago O Ferrão Division of Endocrinology, Division of Endocrinology, Division of Hepatology, Division of Radiology, Diabetes and Metabolism, Federal University of Sergipe, Aracaju, Brazil

Search for other papers by Thiago O Ferrão in
Google Scholar
PubMed Close
,
Carla R P Oliveira
Search for other papers by Carla R P Oliveira in
Google Scholar
PubMed Close
,
João A M Santana
Search for other papers by João A M Santana in
Google Scholar
PubMed Close
,
Francisco A Pereira
Search for other papers by Francisco A Pereira in
Google Scholar
PubMed Close
,
Rita A A Barbosa
Search for other papers by Rita A A Barbosa in
Google Scholar
PubMed Close
,
Anita H O Souza
Search for other papers by Anita H O Souza in
Google Scholar
PubMed Close
,
Rossana M C Pereira
Search for other papers by Rossana M C Pereira in
Google Scholar
PubMed Close
,
Alécia A Oliveira-Santos
Search for other papers by Alécia A Oliveira-Santos in
Google Scholar
PubMed Close
,
Allysson M P Silva
Search for other papers by Allysson M P Silva in
Google Scholar
PubMed Close
,
Francisco J Santana-Júnior
Search for other papers by Francisco J Santana-Júnior in
Google Scholar
PubMed Close
,
Eugênia H O Valença
Search for other papers by Eugênia H O Valença in
Google Scholar
PubMed Close
,
Viviane C Campos
Search for other papers by Viviane C Campos in
Google Scholar
PubMed Close
, and
Manuel H Aguiar-Oliveira
Search for other papers by Manuel H Aguiar-Oliveira in
Google Scholar
PubMed Close

Introduction Nonalcoholic fatty liver disease (NAFLD) is a manifestation of the metabolic syndrome and is associated with very common conditions such as obesity, type 2 diabetes, hypertension, dyslipidemia, and atherosclerosis (1) . NAFLD includes

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-14-0078
Volume/Issue:
Volume 3: Issue 3
Open access
Frederique Van de Velde Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Frederique Van de Velde in
Google Scholar
PubMed Close
,
Marlies Bekaert Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Marlies Bekaert in
Google Scholar
PubMed Close
,
Anja Geerts Department of Hepatology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Anja Geerts in
Google Scholar
PubMed Close
,
Anne Hoorens Department of Pathology, Ghent University Hospital

Search for other papers by Anne Hoorens in
Google Scholar
PubMed Close
,
Arsène-Hélène Batens Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Arsène-Hélène Batens in
Google Scholar
PubMed Close
,
Samyah Shadid Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Samyah Shadid in
Google Scholar
PubMed Close
,
Margriet Ouwens Department of Endocrinology, Ghent University Hospital, Ghent, Belgium
Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center at the Heinrich-Heine-University Duesseldorf, Leibniz Center for Diabetes Research, Duesseldorf, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany

Search for other papers by Margriet Ouwens in
Google Scholar
PubMed Close
,
Yves Van Nieuwenhove Department of Gastrointestinal Surgery, Ghent University Hospital, Ghent, Belgium

Search for other papers by Yves Van Nieuwenhove in
Google Scholar
PubMed Close
, and
Bruno Lapauw Department of Endocrinology, Ghent University Hospital, Ghent, Belgium

Search for other papers by Bruno Lapauw in
Google Scholar
PubMed Close

Introduction An important complication of obesity is the development of nonalcoholic fatty liver disease (NAFLD), which covers a broad histological spectrum from simple steatosis to nonalcoholic steatohepatitis (NASH), and can progress to

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0366
Volume/Issue:
Volume 8: Issue 9
Open access
Tatsuya Kondo Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Tatsuya Kondo in
Google Scholar
PubMed Close
,
Nobukazu Miyakawa Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Nobukazu Miyakawa in
Google Scholar
PubMed Close
,
Sayaka Kitano Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Sayaka Kitano in
Google Scholar
PubMed Close
,
Takuro Watanabe Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Takuro Watanabe in
Google Scholar
PubMed Close
,
Rieko Goto Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Rieko Goto in
Google Scholar
PubMed Close
,
Mary Ann Suico Department of Molecular Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Mary Ann Suico in
Google Scholar
PubMed Close
,
Miki Sato Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Miki Sato in
Google Scholar
PubMed Close
,
Yuki Takaki Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Yuki Takaki in
Google Scholar
PubMed Close
,
Masaji Sakaguchi Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Masaji Sakaguchi in
Google Scholar
PubMed Close
,
Motoyuki Igata Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Chuo-Ward, Kumamoto, Japan

Search for other papers by Motoyuki Igata in
Google Scholar
PubMed Close
,
Junji Kawashima Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Junji Kawashima in
Google Scholar
PubMed Close
,
Hiroyuki Motoshima Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Hiroyuki Motoshima in
Google Scholar
PubMed Close
,
Takeshi Matsumura Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Takeshi Matsumura in
Google Scholar
PubMed Close
,
Hirofumi Kai Department of Molecular Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Hirofumi Kai in
Google Scholar
PubMed Close
, and
Eiichi Araki Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Chuo-Ward, Kumamoto, Japan

Search for other papers by Eiichi Araki in
Google Scholar
PubMed Close

Introduction The increasing worldwide prevalence of obesity and type 2 diabetes, which are closely associated with the development of NAFLD, has become a major healthcare problem ( 1 ). NAFLD encompasses a broad spectrum of disorders ranging

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0084
Volume/Issue:
Volume 10: Issue 5
Open access
Karim Gariani Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals and Geneva University, Geneva, Switzerland

Search for other papers by Karim Gariani in
Google Scholar
PubMed Close
and
François R Jornayvaz Service of Endocrinology, Diabetes, Nutrition and Therapeutic Patient Education, Geneva University Hospitals and Geneva University, Geneva, Switzerland
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland

Search for other papers by François R Jornayvaz in
Google Scholar
PubMed Close

Introduction Nonalcoholic steatohepatitis (NASH) is part of a disease spectrum, nonalcoholic fatty liver disease (NAFLD), which ranges from simple steatosis to fibrosis and ultimately cirrhosis ( 1 , 2 , 3 , 4 ). NASH is, therefore, a

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0490
Volume/Issue:
Volume 10: Issue 2
Open access
Robert Maidstone Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK

Search for other papers by Robert Maidstone in
Google Scholar
PubMed Close
,
Martin K Rutter Centre for Biological Timing, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
Diabetes, Endocrinology and Metabolism Centre, Manchester University NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, UK

Search for other papers by Martin K Rutter in
Google Scholar
PubMed Close
,
Thomas Marjot Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
Oxford Liver Unit, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, UK

Search for other papers by Thomas Marjot in
Google Scholar
PubMed Close
,
David W Ray Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK

Search for other papers by David W Ray in
Google Scholar
PubMed Close
, and
Matthew Baxter Oxford Centre for Diabetes, Endocrinology and Metabolism, and Oxford Kavli Centre for Nanoscience Discovery, University of Oxford, Oxford, UK
NIHR Oxford Health Biomedical Research Centre, and NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK

Search for other papers by Matthew Baxter in
Google Scholar
PubMed Close

-alcoholic fatty liver disease (NAFLD). NAFLD seldom presents as a medical issue but can be detected on routine screening by detection of raised liver enzymes, or altered liver imaging parameters. NAFLD affects over 25% of the worldwide adult population, and the

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-23-0472
Volume/Issue:
Volume 13: Issue 2
Open access
Till Ittermann Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Till Ittermann in
Google Scholar
PubMed Close
,
Rehman Mehmood Khattak Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany
Department of Zoology, Islamia College Peshawar (CU), Peshawar, Pakistan

Search for other papers by Rehman Mehmood Khattak in
Google Scholar
PubMed Close
,
Marcello R P Markus Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Marcello R P Markus in
Google Scholar
PubMed Close
,
Jens-Peter Kühn Institute of Radiology, University Hospital, Carl-Gustav-Carus University, Dresden, Germany

Search for other papers by Jens-Peter Kühn in
Google Scholar
PubMed Close
,
Marie-Luise Kromrey Department of Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Marie-Luise Kromrey in
Google Scholar
PubMed Close
,
Giovanni Targher Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy

Search for other papers by Giovanni Targher in
Google Scholar
PubMed Close
,
Antje Steveling Department of Internal Medicine A, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Antje Steveling in
Google Scholar
PubMed Close
,
Matthias Nauck Institute for Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany
DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, Greifswald, Germany

Search for other papers by Matthias Nauck in
Google Scholar
PubMed Close
, and
Henry Völzke Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany

Search for other papers by Henry Völzke in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD) is a common finding in individuals with obesity or type 2 diabetes mellitus and its prevalence is steeply increasing worldwide ( 1 ). Recent meta-analyses of observational studies revealed

Article Type:
Research Article
Collections:
Thyroid
DOI:
https://doi.org/10.1530/EC-21-0566
Volume/Issue:
Volume 11: Issue 2
Open access
Jun-Xin Yan The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Jun-Xin Yan in
Google Scholar
PubMed Close
,
Bin-Jing Pan The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Bin-Jing Pan in
Google Scholar
PubMed Close
,
Ping-Ping Zhao The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Ping-Ping Zhao in
Google Scholar
PubMed Close
,
Li-Ting Wang The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Li-Ting Wang in
Google Scholar
PubMed Close
,
Jing-Fang Liu The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Jing-Fang Liu in
Google Scholar
PubMed Close
, and
Song-Bo Fu The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China
Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China

Search for other papers by Song-Bo Fu in
Google Scholar
PubMed Close

Introduction Non-alcoholic fatty liver disease (NAFLD), which is the excessive deposition of fat (>5% of the liver weight) in liver cells without causes such as heavy drinking, hypothyroidism, or drugs, is considered a liver manifestation of

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-21-0367
Volume/Issue:
Volume 10: Issue 12
Open access
Khaled Kabarra Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia, USA

Search for other papers by Khaled Kabarra in
Google Scholar
PubMed Close
,
Pegah Golabi Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA

Search for other papers by Pegah Golabi in
Google Scholar
PubMed Close
, and
Zobair M Younossi Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital, Falls Church, Virginia, USA
Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, Virginia, USA
Inova Medicine, Inova Health System, Falls Church, Virginia, USA

Search for other papers by Zobair M Younossi in
Google Scholar
PubMed Close

Introduction Nonalcoholic fatty liver disease (NAFLD) and its subtype of nonalcoholic steatohepatitis (NASH) were first described in the 1980s, coinciding with a rapid rise in epidemic of obesity ( 1 , 2 ). Increasingly, NAFLD has been

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-21-0048
Volume/Issue:
Volume 10: Issue 10
Open access